Theravance Biopharma, Inc. - Special Call Transcript
Ladies and gentlemen, good morning. I'd like to welcome everyone to Theravance Biopharma conference call. (Operator Instructions) Today's conference is being recorded.
And now I would like to turn the call over to Gail Cohen, Vice President, Corporate Communications. Please go ahead.
Good morning, everyone. And thank you for joining our conference call and webcast. Joining us are Rick Winningham, Chief Executive Officer; Brett Haumann; Chief Medical Officer; and Phillip Worboys, Senior Vice President, Research and Translational Science. Following some prepared remarks, we will open the call for questions. A copy of the press release and the slides accompanying this call can be downloaded from our website, or you can call Investor Relations at (650) 808-4045, and we'll be happy to assist you.
As always, I remind you that this conference call will contain forward-looking statements, which involve certain risks and uncertainties, including statements about our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |